Trial Profile
Study of the relationship between antiemetic effect of Aprepitant and plasma concentration of Aprepitant.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Betamethasone; Dexamethasone; Palonosetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 18 Jan 2012 New trial record